Clinical trial participation increases at Phoebe Putney Hospital

Phoebe Putney Memorial Hospital has seen an increase in clinical trials since Medical Tower II opened in February. The new tower houses the Phillip L. Roberts, M.D., Cancer Pavilion, which features Phoebe’s expanded hematology and medical oncology services.

“The new space has allowed us to handle more cases, house more clinical researchers and educators, and allow for a more conducive space to meet with patients about clinical trials,” said Steve Ziemba, director of clinical research and tumor registry.

The new Phoebe Cancer Center has also increased visibility among the pharmaceutical companies, which has increased calls received for grants.

“We have never had this many cases to review at one time before,” said Ziemba. “It is great.”

A clinical trial is a comparison of standard treatments to newer treatments in an effort to discover better methods for the treatment of cancer. These studies are done to evaluate the effectiveness and benefits to patients while watching for possible adverse reactions. Doctors, scientists and other health professionals administer the test(s) according to strict guidelines set by the Food and Drug Administration (FDA). The FDA establishes mandatory guidelines to ensure the maximum safety of the patient.